The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GOG 3088: A randomized phase II study of letrozole versus observation in patients with newly diagnosed uterine leiomyosarcoma.
 
Bradley Corr
Consulting or Advisory Role - AstraZeneca/Merck (Inst); Corcept Therapeutics (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immunogen; Imvax; Merck (Inst); Zentalis (Inst)
Research Funding - Clovis Oncology (Inst); Immunogen (Inst)
 
Michael Sill
Employment - Roswell Park Cancer Institute
Consulting or Advisory Role - MD Anderson Cancer Center
 
Jennifer Klein
No Relationships to Disclose
 
Thomas J. Herzog
Leadership - GOG Foundation
Consulting or Advisory Role - Aadi; AstraZeneca; Caris MPI; Clovis Oncology; Corcept Therapeutics; Eisai; Epsilogen; GlaxoSmithKline; Johnson & Johnson; Merck; Mersana; Seagen
 
Robert L. Coleman
Employment - US Oncology; Vaniam Group
Leadership - Onxeo
Stock and Other Ownership Interests - McKesson/US Oncology Network
Consulting or Advisory Role - Abbvie; Agenus; Alkermes; Alkermes; AstraZeneca/MedImmune; Clovis Oncology; Eisai; Genentech/Roche; Genmab; GlaxoSmithKline; GOG Foundation; Gradalis; Immunogen; Karyopharm Therapeutics; Merck; Merck; Novocure; OncoMed; OncXerna Therapeutics
Research Funding - Alkermes; Amgen (Inst); AstraZeneca/MedImmune; Clovis Oncology (Inst); Immunogen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck; Mirati Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (I)
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Brian M. Slomovitz
Consulting or Advisory Role - AstraZeneca; BioNTech SE; Eisai; EQRx; Genentech; Genmab; Gilead Sciences; GlaxoSmithKline; GOG Foundation; Lilly; Merck; Nuvation Bio; Onconova Therapeutics; Onconova Therapeutics; Regeneron; Seagen